Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor-Reference-Cited by-同舟云学术

Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor

Published:2020-01-13 Issue:2 Volume:12 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Liva Sophia G¹,Tseng Yu‐Chou²,Dauki Anees M¹,Sovic Michael G¹,Vu Trang¹,Henderson Sally E³,Kuo Yi‐Chiu²,Benedict Jason A⁴,Zhang Xiaoli⁴,Remaily Bryan C¹,Kulp Samuel K¹,Campbell Moray¹⁵,Bekaii‐Saab Tanios⁶,Phelps Mitchell A¹⁵,Chen Ching‐Shih²⁷,Coss Christopher C¹⁵^ORCID

Affiliation:

1. Division of Pharmaceutics and Pharmacology College of Pharmacy The Ohio State University Columbus OH USA

2. Division of Medicinal Chemistry and Pharmacognosy College of Pharmacy The Ohio State University Columbus OH USA

3. Department of Veterinary Biosciences College of Veterinary Medicine Ohio State University Columbus OH USA

4. Center for Biostatistics Department of Biomedical Informatics The Ohio State University Columbus OH USA

5. The Ohio State University Comprehensive Cancer Center The Ohio State University Columbus OH USA

6. Mayo Clinic Cancer Center Phoenix AZ USA

7. Department of Medical Research China Medical University Hospital China Medical University Taichung Taiwan

Funder

Office of Extramural Research, National Institutes of Health

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201809910

Reference73 articles.

1. Active GSK3β and an intact β-catenin TCF complex are essential for the differentiation of human myogenic progenitor cells

2. Novel targeted therapies for cancer cachexia

3. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse

4. Animal models for cancer cachexia

5. Cancer-associated cachexia

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Restoring adiponectin via rosiglitazone ameliorates tissue wasting in mice with lung cancer;Acta Physiologica;2024-05-23

2. MODULADOR SELETIVO DO RECEPTOR DE ANDRÓGENO E SUAS APLICAÇÕES CLÍNICAS EM HIPOGONADISMO, CAQUEXIA, SARCOPENIA E CÂNCER DE PRÓSTATA;REVISTA FOCO;2024-04-10

3. Transcriptomic signature of cancer cachexia by integration of machine learning, literature mining and meta-analysis;Computers in Biology and Medicine;2024-04

4. Delineating the role of nuclear receptors in colorectal cancer, a focused review;Discover Oncology;2024-02-19

5. Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia;Pharmacological Research;2024-01